CD30L/CD30 protects against psoriasiform skin inflammation by suppressing Th17-related cytokine production by Vγ4+ γδ T cells
Open Access
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 101, 70-85
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81771753)
This publication has 40 references indexed in Scilit:
- New insights of T cells in the pathogenesis of psoriasisCellular & Molecular Immunology, 2012
- Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in miceJournal of Clinical Investigation, 2012
- Human Keratinocytes' Response to Injury Upregulates CCL20 and Other Genes Linking Innate and Adaptive ImmunityJournal of Investigative Dermatology, 2012
- Epidermal CCR6+ γδ T Cells Are Major Producers of IL-22 and IL-17 in a Murine Model of Psoriasiform DermatitisThe Journal of Immunology, 2011
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in PsoriasisThe Journal of Immunology, 2011
- CD30 Ligand Is a Target for a Novel Biological Therapy against Colitis Associated with Th17 ResponsesThe Journal of Immunology, 2010
- A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasisJournal of the American Academy of Dermatology, 2010
- Skin-Resident T Cells: The Ups and Downs of On Site ImmunityJournal of Investigative Dermatology, 2010
- Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretionJournal of Clinical Investigation, 2006